EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Landscape of Lynch Syndrome in a High-Risk Serbian Cohort: Predominance of MLH1 Variants and Implications for Risk-Based Testing

Marija Djordjic Crnogorac, Valentina Karadzic iD, Teodora Cato, Milena Cavic iD, Neda Nikolic iD, Jelena Spasic iD, Fedja Djordjevic iD, Vladimir Jokic iD, Milan Kocic iD, Miroslav Djurasinovic, Biljana Kukic, Srdjan Nikolic iD und 3 weitere

International Journal of Molecular Sciences · 25.07.2026 · 27 (15) · 6652

DOI: 10.3390/ijms27156652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.07.2026. Verfasst von Marija Djordjic Crnogorac und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department for Genetic Counseling for Hereditary Cancer, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, MutL Protein Homolog 1. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome, caused by germline pathogenic or likely pathogenic variants (PV/LPV) in mismatch repair (MMR) genes. Data on the spectrum of LS-associated variants in Slavic populations, including Serbia, remain limited. Given the high burden of CRC and endometrial cancer and the limited implementation of hereditary CRC screening, characterizing the spectrum of germline variants in clinically selected high-risk individuals is important for improving genetic testing strategies, risk assessment, and clinical management. Between 2018 and 2025, 176 individuals underwent germline testing for hereditary CRC syndrome based on the Amsterdam/Bethesda criteria, validated LS risk prediction models, and/or family history (FH). Next-generation sequencing (NGS) was performed using the Illumina TruSight Hereditary Cancer Panel, and variants were classified according to American College of Medical Genetics and Genomics and Association for Molecular Pathology (ACMG/AMP) guidelines. PV/LPVs in MMR genes were identified in 27/176 (15.3%) and were associated with positive FH of LS-related tumors (p = 0.0001). Most PV/LPVs were identified in MLH1 (10.2%), followed by MSH2 (4.0%) and MSH6 (1.1%), with no PV/LPVs identified in PMS2. Additionally, no pathogenic sequence-level EPCAM variants detectable by the applied panel-based NGS approach were identified. Recurrent MLH1 variants were observed in multiple families, and two previously unreported MLH1 variants were identified. This first systematic analysis of a clinically selected high-risk Serbian cohort provides novel data on the spectrum of LS-associated variants in this referral population, demonstrates the predominance of MLH1 variants, and supports broader implementation of genetic testing, tumor screening, and genetic counseling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal Neoplasms, Hereditary NonpolyposisMutL Protein Homolog 1HumansFemaleSerbiaGenetic TestingGerm-Line MutationGenetic Predisposition to DiseaseMiddle AgedMaleHigh-Throughput Nucleotide SequencingAdultDNA Mismatch RepairAgedCohort Studies

Stichwörter der Autor:innen

Lynch syndromeMLH1 mutationsdeveloping countriesgenetic screeninggenetic testing criteriahereditary nonpolyposis colorectal cancer

Substanzen

MutL Protein Homolog 1MLH1 protein, human

Autor:innen und Institutionen

  • Department for Genetic Counseling for Hereditary Cancer, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.
  • Department for Experimental Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.
  • Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.
  • Clinic for Surgical Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.
  • Department for Medical Oncology, Oncology Institute of Vojvodina, University of Novi Sad, 21000 Novi Sad, Serbia.
  • Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.

ORCID-Profile: Valentina Karadzic, Milena Cavic, Neda Nikolic, Jelena Spasic, Fedja Djordjevic, Vladimir Jokic, Milan Kocic, Srdjan Nikolic, Marijana Milovic

Förderung

  • European Commission

Zitieren

APA

Djordjic Crnogorac, M., Karadzic, V., Cato, T., Cavic, M., Nikolic, N., Spasic, J., Djordjevic, F., Jokic, V., Kocic, M., Djurasinovic, M., Kukic, B., Nikolic, S., Ristic, M., Milovic, M., & Krivokuca, A. (2026). Genetic Landscape of Lynch Syndrome in a High-Risk Serbian Cohort: Predominance of MLH1 Variants and Implications for Risk-Based Testing. International Journal of Molecular Sciences, 27(15), 6652. https://doi.org/10.3390/ijms27156652

Vancouver

Djordjic Crnogorac M, Karadzic V, Cato T, Cavic M, Nikolic N, Spasic J, et al. Genetic Landscape of Lynch Syndrome in a High-Risk Serbian Cohort: Predominance of MLH1 Variants and Implications for Risk-Based Testing. International Journal of Molecular Sciences. 2026;27(15):6652. doi:10.3390/ijms27156652

BibTeX
@article{DjordjicCrnogorac2026,
  author = {Djordjic Crnogorac, Marija and Karadzic, Valentina and Cato, Teodora and Cavic, Milena and Nikolic, Neda and Spasic, Jelena and Djordjevic, Fedja and Jokic, Vladimir and Kocic, Milan and Djurasinovic, Miroslav and Kukic, Biljana and Nikolic, Srdjan and Ristic, Marija and Milovic, Marijana and Krivokuca, Ana},
  title = {Genetic Landscape of Lynch Syndrome in a High-Risk Serbian Cohort: Predominance of MLH1 Variants and Implications for Risk-Based Testing},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {15},
  pages = {6652},
  doi = {10.3390/ijms27156652}
}
Kostenlos starten →